Delivery Order SPE2DR25D1109-SPE2DR26FFJ3L
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $15,339.52 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count unit dose packages) on August 21, 2025, with an ultimate completion date of August 22, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $6,840.95 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on November 24, 2025, with completion targeted for November 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its Corporate Office location in...
- The Defense Logistics Agency awarded a delivery order valued at $15,679.59 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 21, 2025, with an ultimate completion date of August 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $14,532.44 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count unit dose packaging) on November 26, 2025, with completion scheduled for November 28, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of the company's pharmaceutical supply services to federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's Corporate Office location in...
- The Defense Logistics Agency awarded a $26,071.80 delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of RINVOQ ER 15 mg tablets (30-unit bottles). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 18, 2025. AmerisourceBergen Drug Corp will perform this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $10,772.76 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-unit package) on July 25, 2025, with completion expected by July 28, 2025. This competitively awarded, firm fixed-price delivery order represents a procurement of pharmaceutical inventory supporting military healthcare operations. The contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $4,403.45 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) on December 3, 2025, with a completion date of December 4, 2025. This firm fixed-price, non-set-aside delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) valued at $12,603.88 under a firm fixed-price contract. The award was made on December 3, 2025, with an ultimate completion date of December 4, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp will perform this order from its corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $39,350.52 delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15mg tablets (30-count supply) on December 17, 2025, with completion scheduled for December 18, 2025. This non-competitive delivery order was issued under a firm fixed-price arrangement and performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) valued at $70,077.70 on November 17, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply role within the federal healthcare procurement system. The products will be delivered to the...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFJ3LDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $25,897.92 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on December 19, 2025, with an ultimate completion date of December 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's headquarters and primary distribution hub. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies brand-name and generic medications across multiple therapeutic domains to the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.9k | 12/18/25 |